Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
boston blog main
boston top stories
3
×
life sciences
national blog main
clinical trials
deals
fda
startups
480 biomedical
arsenal medical
azacitidine
beta-thalassemia
biotech ipos
bob langer
chronic rhinosinusitis
covid-19
dacogen
decitabine
dna
drug delivery
dyne therapeutics
epigenetics
epizyme
farydak
flagship pioneering
fulcrum therapeutics
genzyme
george whitesides
inflammation
insulated genomic domains
investing
ipo
kaleido biosciences
keros therapeutics
lyra therapeutics
mahesh karande
medical device
metacrine
What
developing
3
×
therapeutics
3
×
biotech
company
ipo
medicines
million
new
raised
aims
approach
based
brings
called
debut
debuts
disorders
drug
drugs
dyne
dyne’s
epigenetic
epigenetics
field
flagship’s
genetic
late
lyra
markets
morning
muscle
muscular
nose
noses
omega
persistently
preclinical
public
raises
rare
Language
unset
Current search:
developing
×
therapeutics
×
" boston top stories "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further